Catalog classification, reference sizes, lab math links, and source-backed data. Educational use only — not medical advice.
Researched for: PepTools vendor-neutral scientific reference catalog
Also known as: deoxycholic acid injection, deoxycholic acid 10 mg/mL injection, deoxycholic acid 20 mg/2 mL injection, ATX-101
Deoxycholic acid is a C24 bile acid. In the approved injectable formulation, subcutaneous administration produces local disruption of adipocyte cell membranes and cell lysis. An FDA-approved generic deoxycholic acid injection is specified as 20 mg in 2 mL, equivalent to 10 mg/mL.
Catalog descriptions reflect research context only. Not a medical claim or treatment recommendation.
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
The approved generic product is an injectable pharmaceutical formulation, not a general-purpose laboratory reagent. The FDA clinical pharmacology review evaluated a 100 mg single subcutaneous treatment dose administered as 50 injections of 0.2 mL on a 1 cm grid; this is recorded as study-reference information only. The reference formulation contains benzyl alcohol, dibasic sodium phosphate, sodium chloride, sodium hydroxide, hydrochloric acid for pH adjustment, and water for injection; excipient composition of the generic product was not independently confirmed from the generic product label.
Supplementary research context only. Not medical advice or a treatment recommendation.
CAS RN 83-44-3; PubChem CID 222528; molecular formula C24H40O4; molecular weight 392.57 g/mol; FDA UNII 005990WHZZ
FDA approved an abbreviated new drug application for deoxycholic acid injection 20 mg/2 mL (10 mg/mL) as bioequivalent and therapeutically equivalent to the reference listed drug. The FDA-labeled injectable formulation is a clear, colorless, sterile solution for subcutaneous use. Current FDA labeling limits established use to the submental region in adults; safety and effectiveness outside that region have not been established and are not recommended. The 2026 FDA labeling update added warnings concerning serious adverse reactions associated with administration outside the submental region and injection-site nodules or masses.
Reflects published research. Educational reference — not a recommendation for use.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Published articles on this site that mention Generic deoxycholic acid injection or one of its catalog aliases.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.